PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
about
Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer.Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CC.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ Uptake.Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools.Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CT.Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T Cells.Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.Uptake of Radium-223 Dichloride and Early [(18)F]NaF PET Response Are Driven by Baseline [(18)F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients.Imaging Characteristics and First Experience of [68Ga]THP-PSMA, a Novel Probe for Rapid Kit-Based Ga-68 Labeling and PET Imaging: Comparative Analysis with [68Ga]PSMA I&T.The use of PET/CT in prostate cancer.Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone.Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007.Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted 18F-DCFPyL Positron Emission Tomography Imaging.Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis.Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents
P2860
Q31137270-43DC7D72-84F0-4CF1-B9DD-B29F71A27A9CQ31145236-BE72C346-0425-4FCF-8421-D2A787651478Q39307896-0B6AB80E-74E9-4A1A-9D18-4E5EFA0441E8Q45105171-F82AB277-7447-4D75-B9CA-F4419E020953Q46411145-7B9BBA91-D316-4166-97B2-5289861823F7Q47123011-8B4AEF9E-7616-4AC6-A2D8-4E4FCC9C7707Q47757361-BB497AFF-AFD6-489C-889D-5DE7E6240FFAQ47829959-45864A86-1EC4-417D-82D3-2123FC725301Q48194054-286C80E2-B5B7-4125-8EC7-B68E02720490Q48221776-091E6B5D-D536-4115-B160-AB93C91E40E7Q49919217-DA477B76-E7C6-42D9-95EE-2A882267433CQ51838938-889A63A5-EEA5-446A-BC56-71B88BC24A31Q52590598-142688C9-DF6C-4C4F-BF39-34CEDD7560A1Q52816283-B95E7D7C-EA6C-4CA7-9BD7-F08E1060CCA0Q55432719-27234A15-D75B-4147-AAA9-369EA3CB935AQ55601670-03F90F8E-35A2-447E-8137-AFA0E4EE39C2Q59130960-A9600E39-8620-4466-85D7-5F2245DBE996
P2860
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PSMA-Based [
@nl
PSMA-Based [(18)F]DCFPyL PET/C ...... th Metastatic Prostate Cancer.
@en
type
label
PSMA-Based [
@nl
PSMA-Based [(18)F]DCFPyL PET/C ...... th Metastatic Prostate Cancer.
@en
prefLabel
PSMA-Based [
@nl
PSMA-Based [(18)F]DCFPyL PET/C ...... th Metastatic Prostate Cancer.
@en
P2093
P2860
P1476
PSMA-Based [(18)F]DCFPyL PET/C ...... th Metastatic Prostate Cancer.
@en
P2093
Amanda L Blackford
Emmanuel S Antonarakis
Esther Mena
Katarzyna J Macura
Mario Eisenberger
Martin G Pomper
Michael Carducci
Robert F Dannals
Ronnie C Mease
P2860
P2888
P304
P356
10.1007/S11307-016-0957-6
P577
2016-04-14T00:00:00Z
P6179
1011382226